Table 7. Patients with BRAF V600E mutation.
Sex | Age | Location | Antibody | DpR (%) | PFS (months) | OS (months) | |
---|---|---|---|---|---|---|---|
Case 1 | F | 54 | Left | Cmab | -38 | 5.1 | 10.0 |
Case 2 | F | 64 | Right | Bmab | 7 | 8.2 | 12.9 |
Case 3 | F | 52 | Right | Bmab | -24 | 10.3 | 25.2 |
Abbreviations: F, female; Cmab, cetuximab; Bmab, bevacizumab; DpR, depth of response; PFS, progression free survival; OS, overall survival.